Navigation Links
Verenium Appoints John F. Dee to Board of Directors
Date:5/12/2008

- Adds significant strategic biotech business experience -

CAMBRIDGE, Mass., May 12 /PRNewswire-FirstCall/ -. Verenium Corporation (Nasdaq: VRNM), a pioneer in the development of next-generation cellulosic ethanol and high-performance specialty enzymes, today announced the appointment of John F. Dee to its Board of Directors. The Company also announced that Geoffrey Hazlewood, Ph.D., Senior Vice President of Research, has resigned for personal reasons effective May 31, 2008 and will be returning to his native England. Dr. Hazlewood will remain as an exclusive consultant to the Company and will also join its scientific advisory board, enabling him to play an ongoing role in bringing many of Verenium's important research projects to a successful conclusion.

"We are very pleased that John has joined the Verenium Board, as his extensive executive-level experience working with emerging-growth companies in strategic, financial and operational development will contribute valuable perspective while the Company rapidly accelerates into a commercial-scale producer of next-generation biofuels," said Carlos A. Riva, President and Chief Executive Officer at Verenium. "I'd also like to thank Geoff Hazlewood for his many years of significant service and contributions to Verenium and look forward to his continuing involvement."

Mr. Dee served as President, Chief Executive Officer, and Director of Hypnion, Inc., a privately-held neurosciences drug discovery company, from its founding in July 2000 through its $315 million acquisition by Eli Lilly and Company in April 2007. Before Hypnion, Mr. Dee spent three years as a "turn- around" CEO, specializing in reviving under-performing biotechnology companies including Genta, Inc. Prior
'/>"/>

SOURCE Verenium Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Verenium Reports Financial Results for the First Quarter 2008
2. Verenium Corporation to Present at Piper Jaffray Clean Technology & Renewables Conference
3. Verenium Explores Bacterial Genes Inside Termite Guts to Understand How Wood is Broken Down and Converted to Energy
4. Verenium Corporation to Present at the Pacific Growth Equities 2007 Clean Technology & Industrial Growth Conference
5. Verenium Advances Its Development Work With Cargill on a New Food-Related Product
6. Verenium Corporation to Present at the Upcoming Cowen and Company Clean Energy Conference
7. Cytochroma Appoints R. Richard Wieland II As CFO
8. InSet Technologies Appoints Jon Tremmel to its Board of Directors
9. Nventa Appoints John Varian to Board of Directors
10. Kendle Appoints Patricia Williams Vice President, Commercial Operations
11. Biomoda Appoints Three Business Leaders to Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... ... 2015 , ... Apex Therapeutics announced today that company CEO, David Broecker provided ... , The presentation took place on Tuesday, June 16 and provided an update on ... for the treatment of pancreatic cancer. A copy of the company overview can ...
(Date:6/30/2015)... /PRNewswire/ - Resverlogix Corp. ("Resverlogix") (TSX:RVX) announced today ... have approved the resolutions relating to: (i) a ... units at a price of $2.67 per unit ... of one common share and 0.075358 common share ... million; and (ii) the amendment to Resverlogix,s articles ...
(Date:6/30/2015)... ... June 30, 2015 , ... uBiome ... new insights on mechanics of fecal microbiota transplantation in C. difficile patients. , ... microbiome of patients undergoing fecal microbiota transplantation (FMT) as a treatment for Clostridium ...
(Date:6/30/2015)... DIEGO , June 30, 2015  The ... Education in Biosciences (CCE/Bio) and UC San Diego ... fermentation, to be held Aug.  12 – 14, ... ).  This three-day workshop provides an intense exposure ... industrial biotechnology, and is well-suited to biologists, process ...
Breaking Biology Technology:Apex Therapeutics Presented Company Overview at This Year’s BIO International Convention in Philadelphia, PA 2Resverlogix Corp. Shareholders Approve Matters Relating to Licensing and Equity Arrangement 2Resverlogix Corp. Shareholders Approve Matters Relating to Licensing and Equity Arrangement 3uBiome and OpenBiome Partner for Microbiome Study in FMT Patients 2uBiome and OpenBiome Partner for Microbiome Study in FMT Patients 3UC San Diego Extension to Offer Third Annual Microbial Fermentation Workshop 2
... temptation to set forth predictions for 2007 is just too hard ... predictions for the next 12 months if you'll send me yours. ... foresights? - to chris@guidewiregroup.com before the end of the ... 2.0 goes away , ,Well, not Web 2.0 the development ...
... ConjuGon, Inc ., a privately-held biopharmaceutical company, has ... Rosetta Partners, a private investment firm based in Lake ... capital for clinical trials of its treatment for the ... and testing of its core technology - therapies for ...
... in a three-part series of op-ed pieces on corporate ... column, are written by associates in the Madison-based public ... ,According to the Association of Certified Fraud Examiners ... someone saying something (tips, 34.2 percent; internal audit, 20.2 ...
Cached Biology Technology:Bold prediction: Web 2.0 goes away in 2007 2Bold prediction: Web 2.0 goes away in 2007 3ConjuGon raises $3.3 million to fund clinical trials 2I can tell you - you're my lawyer, right? 2I can tell you - you're my lawyer, right? 3I can tell you - you're my lawyer, right? 4I can tell you - you're my lawyer, right? 5I can tell you - you're my lawyer, right? 6
(Date:6/23/2015)... , June 23, 2015  Crossmatch™, ... and authentication solutions, today announced enhanced functionality of ... authentication solution.  The enhancements build on the ... the DigitalPersona Altus platform and provide expanded ... In today,s environment of increasing ...
(Date:6/17/2015)... and HILDEN, Germany , June 17, 2015 ... Frankfurt Prime Standard: QIA) today launched new Investigator ® ... laboratories in the United States . The ... analyze multiple key genomic markers (short tandem repeats or STRs) ... Sensor to evaluate the quality of DNA in each sample, ...
(Date:6/16/2015)... , June 16, 2015  With the increasing ... security remains a top concern. The recent compromise of ... the need for strong authentication within government agencies. ... a biometric one-time password (OTP) authenticator, has been submitted ... (FIPS) 140-2 Level 3 validation for tamper proofing. ...
Breaking Biology News(10 mins):Crossmatch Releases Enhanced DigitalPersona Altus Advanced Authentication Functionality 2QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 2QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 3QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 4QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 5Government Ready Biometric Security Approaching as HYPR Corp. Files FIPS 140-2 Level 3 Validation for Its Proprietary Biometric Token 2Government Ready Biometric Security Approaching as HYPR Corp. Files FIPS 140-2 Level 3 Validation for Its Proprietary Biometric Token 3
... of Rostock in Germany has developed a new way to ... using less energy than before. It,s expected that this breakthrough ... diverse range of applications; including transport and medical devices. ... open access journal Materials Today , reports on the ...
... research by UM bioclimatology Assistant Professor Ashley Ballantyne ... Arctic temperatures during the Pliocene era. His research ... the July issue of Nature Geoscience. The full ... Palaeoecology: An International Journal for the Geosciences ., ...
... sector, are accessible marine resources as they grow in ... every year and have become an important part of ... based on macroalgae for bioenergy, cosmetics and biomedicine. , ... led by the Spanish National Research Council (CSIC) that ...
Cached Biology News:Cool it, quick: Rapid cooling leads to stronger alloys 2Japan, China and South Korea account for 84 percent of the macroalgae patents 2
Anti-Chicken IgY, (IgG) F(ab')2 Fragment Specific....
Presenilin 2 Immunogen: Synthetic peptide corresponding to residues 31-47 of human Presenilin 2. Storage: -20 C, Avoid Freeze/Thaw Cycles...
SHP-2 Antibody...
200 μg per ml DNA in 10 SSPE, 2 Denhardt's...
Biology Products: